Drug Executive Collapses During Oval Office Press Conference
During a Thursday press conference in the Oval Office, a drug executive suddenly collapsed while President Donald Trump announced a deal aimed at reducing prices for obesity drugs. The event was cut short as attendees responded to the emergency.
Details of the Incident
The executive, identified as Gordon Findlay, the global brand director for Novo Nordisk, fainted while Eli Lilly CEO David Ricks was addressing the press. Ricks noticed and asked,
“Are you OK? Gordon, are you OK?”
Response and Context
Dr. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, quickly intervened as Findlay fell to his knees and collapsed. The press were then asked to leave the room.
Event Background
- President Trump was announcing a new agreement with drugmakers Eli Lilly and Novo Nordisk.
- The deal aims to expand coverage and lower prices for obesity treatments Zepbound and Wegovy.
- Health and Human Services Secretary was also present when the executive collapsed.
“President Donald Trump looks on as Administrator for the Centers for Medicare & Medicaid Services Dr. Mehmet Oz and others help a man identified as Gordon Findlay.” — Getty Images
Author's summary: A sudden medical emergency interrupted President Trump's announcement of a drug price deal, highlighting the unpredictability of live events and the prompt response of health officials present.